FIGURE 3 Effect of DDR1 expression on different cancers prognosis using PrognoScan and Kaplan – Meier plotter databases. (A – H) Survival curves were assessed using PrognoScan database. Survival curves of OS in blood cancer (AML) (A) , brain cancer (B) , ovarian cancer (C) , lung cancer (D) , and prostate cancer (E) are shown. Survival curves of DSS in blood cancer (MM) (F) and breast cancer (G) are showed. Survival curve of DFS in the colorectal cancer (H) is shown. (I – P) Survival curves were analyzed using Kaplan – Meier plotter database. Survival curves of OS (I) and RFS (J) in breast cancer, OS (K) and RFS (L) in ovarian cancer, OS (M) and FP (N) in lung cancer, and OS (O) and PPS (P) in gastric cancer. AML, acute myelogenous leukemia; MM, multiple myeloma; OS, overall survival; DSS, disease-speci fi c survival; DFS, disease-free survival; RFS, relapse-free survival; FP, fi rst progression; PPS, post-progression